Overview

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

Status:
Terminated

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

This study is to verify the efficacy of fluvoxamine maleate given for 10 weeks in treatment of children and adolescents with obsessive-compulsive disorder

Phase:

Phase 4

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Fluvoxamine
Maleic acid